Clinical trial
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight…
NCT00129246 · Yale University, Other · Completed
Key facts
| NCT number | NCT00129246 |
|---|---|
| Title | Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain |
| Official title | Naltrexone & Bupropion to Stop Smoking With Less Weight Gain |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Smoking, Nicotine Dependence |
| Intervention type | Drug |
| Interventions | Naltrexone, Bupropion |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Aug 11, 2005 |
| Last update posted | Dec 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: